Insulin and glucagon release from monolayer pancreatic islet cell cultures were inhibited in a dose-response fashion by various enkephalins. Morphine, however, stimulated insulin and glucagon release. Both effects were blocked by naloxone, while naloxone alone had no effect. In isolated and denervated islet cells, opiates directly influence secretion from islet cells. DIABETES 29:84-86, January 1980. E ndogenous opiates (endorphins and enkephalins) are widely distributed in the nervous system and gastrointestinal tract of animals, including man. They have been shown to affect rates of neuronal transmission and the secretion of several pituitary hormones (ADH, prolactin, growth hormone, and gonadotrophins).
stain for insulin, glucagon, somatostatin (SRIF), gastric inhibitory polypeptide, secretin, gastrin, and pancreatic polypeptide. 9 " 15 Experiments were performed on the fourth day of culture. Experimental incubation medium was Eagle's minimal essential medium supplemented with nonessential amino acids, Earle's salts, and 0.5% (v/v) heat-inactivated fetal bovine serum. All dishes were preincubated for 2 h in 5.5 mM glucose. This was followed by a 1-h incubation during which secretagogues plus varying concentrations of opiate were added to experimental cultures and compared with control cultures with segretagogues alone. Insulin and glucagon were measured in the incubation media by radioimmunoassay. 16 ' 17 Statistical analysis was performed using Newman-Keul's multiple comparison procedure. 18 The naturally occurring peptides leucine-and methionine-enkephalin, D-ala 2 -leucine-, and D-phe 4 -leucine-enkephalin analogues were generously provided by Dr. Richard J. Miller of the University of Chicago.
RESULTS
With glucose 16.5 mM, the naturally occurring opiates leucine-enkephalin (LEK) and methionine-enkephalin (MEK) produced, over a concentration range of 0.02 to 2.0 /Jvi, a dose-related suppression of both insulin and glucagon release ( Figure 1 ). D-ala 2 -leucine-enkephalin (DLE) is an enkephalin analogue that has been reported to resist metabolic degradation. 1 Over the same concentration range, DLE produced a similar suppression of insulin and glucagon release (Figure 1 ). This suggests that the natural peptides are not significantly degraded in our system. D-phe 4 -leucine-enkephalin is an analogue that has been shown to be less potent in classic opiate bioassays. 1 It required a 10-fold greater concentration than MEK, LEK, or DLE to achieve a similar suppression of insulin and glucagon release.
Enkephalins also reversed insulin and glucagon release stimulated by other secretagogues. The effects of 10 mM arginine and 5 mM theophylline were both significantly diminished by the addition of enkephalin (2.0 (M) to 74% and 83%, respectively, of control insulin levels, and 50% and 45%, respectively, of control glucagon levels. Morphine sulfate, an opiate of plant origin, had an effect opposite to that of enkephalin. Morphine (20 (M) significantly enhanced insulin and glucagon secretion (Figure 2 ). Under similar conditions (5.5 mM glucose plus 10 mM arginine), enkephalin (1.2 juJvi) inhibited insulin and glucagon levels by 36% and 50%, respectively.
The effects of both enkephalins and morphine were reversed by the opiate antagonist naloxone (20 /Jvi). Naloxone alone did not influence hormonal secretion.
DISCUSSION
In a system free of neuronal input, opiates were found to influence insulin and glucagon secretion. This would suggest that opiates have a direct effect on islet cells and, therefore, may have a role in glucose homeostasis. 19 found no significant change in insulin, glucagon, or glucose levels with intravenous infusion of a longacting enkephalin in humans. However, serum growth hormone, prolactin, TSH, and cortisol were significantly altered in those subjects. Thus, although widespread effects of enkephalins were observed, specific effects on insulin and glucagon secretion may have been obscured. Our findings in an isolated system are in agreement with Ipp et al., 5 who found morphine enhanced stimulated insulin and glucagon secretion in the perfused dog pancreas;
Although opiates perturb the secretion of several pituitary hormones in vivo, they have no effect on their release from isolated pituitary glands. 3 The site of opiate action is the hypothalamus, where they influence the activity of neurosecretory cells that secrete releasing hormones into the hypophyseal portal system. By altering releasing hormone concentrations, opiates secondarily modify pituitary hormone release. This modulating role is analogous to the postulated function of opiates in the spinal cord, where they alter afferent impulse conduction by interacting with presynaptic neurons. By increasing presynaptic membrane potentials, the threshold for conduction is increased and the rate of firing is decreased. 20 The influence of opiates on insulin and glucagon secretion in an isolated and denervated system implies a different mechanism of opiate action: direct effect on islet secretory cells.
Ipp et al. 5 found that both morphine and /3-endorphin decreased SRIF secretion in the isolated perfused dog pancreas. Since a fall in SRIF levels is compatible with greater secretion of insulin and glucagon, they raised the possibility that the effects on secretion from A-and D-cells may be mediated through suppression of SRIF release. Because pancreatic monolayers also contain SRIF cells, it is conceivable that enkephalins and morphine also act on D-cells in the cultured islet system. Recently, at least two different classes of opiate receptors have been identified in rat brain. 21 The //,-receptor is more specific for morphine and other narcotics while the 8-receptor binds enkephalin with much greater affinity. Furthermore, Martin et al. 22 have shown that activation of different opiate receptors may result in opposite physiologic responses. Whether the disparate effects of morphine and enkephalin on insulin and glucagon secretion in rat monolayer islet cultures are due to interaction with different classes of opiate receptors remains to be determined.
A physiologic role of opiates in glucose-homeostasis is as yet speculative. Due to their well-documented metabolic instability, enkephalins are unlikely to function as circulating hormones. /3-endorphin has been measured in the circulation. 23 But even after stimulation with metyrapone, it is present only in femtomole amounts. Ipp et al. 5 found that micromolar concentrations of /3-endorphin were necessary to alter insulin and glucagon secretion in the perfused dog pancreas.
It is conceivable that endogenous opiates reach the islets by neural pathways and modify insulin and glucagon secretion either by directly interacting with A-and B-cells or by influencing SRIF secretion from D-cells, which in turn perturbs adjacent cells.
The finding, in animals, of met-enkephalin in nerve terminals of other endocrine glands (adrenal medulla) is consistent with our hypothesis. 24 In addition, a nonpeptide opiate DIABETES, VOL. 29. JANUARY 1980 with chemical properties similar to morphine was found in the nervous system of animals. 25 This makes the postulated presence of "morphine-specific" receptors more physiologically reasonable.
In conclusion, despite the uncertain nature of the exact mechanism of action, our results suggest that opiates have a direct effect on the hormone-producing cells of the islets of Langerhans.
